Novel mutation of EXT2 identified in a large family with multiple osteochondromas

Mol Med Rep. 2016 Nov;14(5):4687-4691. doi: 10.3892/mmr.2016.5814. Epub 2016 Oct 6.

Abstract

Multiple osteochondromas (MO), also known as hereditary multiple exostoses, is an autosomal dominant bone disorder. Mutations in exostosin glycosyl transferase‑1 (EXT1) and exostosin glycosyl transferase‑2 (EXT2), including missense, nonsense, frameshift and splice‑site mutations, account for up to 80% of reported cases. The proteins EXT1 and EXT2 form a hetero‑oligomeric complex that functions in heparan sulfate proteoglycan biosynthesis. A heterozygous EXT2 mutation, c.939+1G>T, was identified in a five‑generation 33‑member MO family, and was present in all 13 affected members. The mutation results in deletion of exon 5 in the mRNA, producing a frameshift that leads to a premature termination codon. The present study extends the mutational spectrum of EXT2.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Child
  • DNA Mutational Analysis
  • Exostoses, Multiple Hereditary / diagnosis*
  • Exostoses, Multiple Hereditary / genetics*
  • Exostosin 2
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • N-Acetylglucosaminyltransferases / genetics*
  • Pedigree
  • Phenotype
  • RNA Splice Sites
  • Radiography
  • Tomography, X-Ray Computed
  • Young Adult

Substances

  • RNA Splice Sites
  • N-Acetylglucosaminyltransferases
  • Exostosin 2